Product Detail

Product Description BUPRENORPHINE HCl PF (C) INJECTABLE STRENGTHS: 0.15 mg/ml , 0.6 mg/ml NDC: 49452825301, G9064-0122-10

Recall Number V-220-2013

Classification Class II
Code Info LOTS: 130107:18@27, 130115:03@22, 130308:34@45, 130405:34@40, 130416:69@97, 1302026:46@22, 130118:95@126, 130401:77@17, 130521:85@124

Product Distributed Qty 8,068 units

Reason For Recall Diamondback Drugs is recalling Buprenorphine HCL PF (C) Injectable due to an issue with the long-term stability of the product. Use of the Buprenorphine HCL PF (C) Injectable may not deliver the level of therapeutic relief from pain as expected.

Event Detail

Event Id 65481

Product Type Veterinary

Status Ongoing

Recalling Firm
Diamondback Drugs of Delaware, LLC
City Scottsdale

State AZ
Country US

Voluntary / Mandated Voluntary: Firm Initiated

Recall Initiation Date 2013-06-10

Initial Firm Notification of Consignee or Public Letter

Distribution Pattern Nationwide in the US